Since our findings indicate that ZCCHC4 promotes the proliferation of esophageal cancer cells and enhances cisplatin resistance, we investigated whether knockdown of ZCCHC4 inhibits the progression of esophageal cancer and increases sensitivity to cisplatin in vivo. This evidence concerns the gene ZCCHC4 and esophageal cancer.